Robeco Institutional Asset Management
AMED

Robeco Institutional Asset Management’s Amedisys AMED Stock Holding History

Robeco Institutional Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,175
Closed -$8.86M – 918
2021
Q2 		$8.86M Sell
36,175
-13,476
-27% -$3.54M 0.02% 500
2021
Q1 		$13.1M Sell
49,651
-7,290
-13% -$2.06M 0.03% 423
2020
Q4 		$16.7M Sell
56,941
-2,877
-5% -$738K 0.04% 364
2020
Q3 		$14.1M Sell
59,818
-11,764
-16% -$2.67M 0.04% 361
2020
Q2 		$14.2M Buy
71,582
+34,814
+95% +$6.49M 0.05% 372
2020
Q1 		$6.75M Buy
36,768
+8,038
+28% +$1.43M 0.03% 491
2019
Q4 		$4.79M Hold
28,730
– – 0.02% 605
2019
Q3 		$3.76M Sell
28,730
-62,714
-69% -$8.16M 0.01% 640
2019
Q2 		$11.1M Sell
91,444
-61,535
-40% -$7.3M 0.04% 443
2019
Q1 		$18.9M Buy
152,979
+19,983
+15% +$2.51M 0.07% 358
2018
Q4 		$15.4M Buy
132,996
+82,142
+162% +$9.68M 0.07% 334
2018
Q3 		$6.35M Buy
+50,854
New +$5.62M 0.03% 518

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Robeco Institutional Asset Management's AMED Position: Q3 2021 in Review

Robeco Institutional Asset Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 36,175 shares — an estimated $8.86M sold.

Robeco Institutional Asset Management first reported a position in AMED in Q3 2018 and held it in 12 quarters. The position peaked at $18.9M in Q1 2019. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Robeco Institutional Asset Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 36,175 Amedisys shares in Q3 2021, an estimated $8.86M.
  • Robeco Institutional Asset Management first reported a position in Amedisys in Q3 2018 and held it in 12 quarters.
  • Robeco Institutional Asset Management's Amedisys position peaked at $18.9M in Q1 2019.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2021, filed 20 Oct 2021.